Even as U.S. lawmakers target TikTok, the social media app is morphing into a global giant with tentacles that reach far into the turf of Google, Facebook, Snap and others. Read More...
Motley Fool
Is Veru a Buy?
Biotech company Veru (NASDAQ: VERU) aims to make products to treat cancer and infectious diseases. Instead, it has been the company’s potential COVID treatment that has been getting investors excited. With the stock recently crashing and now at its lowest levels since March, is now the time to buy shares of Veru?
Add Comment